GL1X · GenesisL1 explorer

MolNFT v1 · #157944 · protein

Cyclic gmp-AMP synthase in complex with compound 16 inhibitor: 7- hydroxy-N-methyl-5-PHENYLPYRAZOLO[1,5-A]PYRIMIDINE-3-carboxamide

6NFG: “Cyclic gmp-AMP synthase in complex with compound 16 inhibitor: 7…”. X-ray diffraction, 2 ligands (KKP, ZN), 8 pockets (best druggability 0.74). MolNFT v1 #157944 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6NFG
Type
protein
Length
694 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclic gmp-AMP synthase
EC
2.7.7.86
UniProt
Q8N884
Ligands
KKP, ZN
Pockets
8 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclic gmp-AMP synthase (EC 2.7.7.86)protein34846% helix, 18% strandQ8N884
BCyclic gmp-AMP synthase (EC 2.7.7.86)protein34645% helix, 18% strandQ8N884

Ligands and binding sites

  • KKP · 7-hydroxy-N-methyl-5-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17310.740.7977KKP
26560.720.7962KKP
32440.570.7824empty
41330.430.7525empty
5670.350.7717empty

Interfaces

1 interface between chains.

  • A–B · 710 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 6NFG · CYCLIC GMP-AMP SYNTHASE in complex with compound 16 inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8N884 · AlphaFold monomer V2.0 prediction for cyclic gmp-AMP synthase (Q8N884) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.